GenScript Bio (01548): CARVYKTI's fourth quarter trade sales revenue is approximately 334 million US dollars.

22/01/2025

Kingsley Biotechnology (01548) released an announcement regarding the collaboration between Legend Biotech and Janssen Biotech...

GENSCRIPT BIO (01548) announced that, based on the cooperation and licensing agreement entered into by Legend Biotech and Janssen Biotech, Inc. (Johnson & Johnson) on December 21, 2017, CARVYKTI is expected to generate approximately $334 million in trade sales revenue by the end of the quarter ending December 31, 2024.

Shougang Langze (02553) has published a supplementary prospectus, expecting to be listed on July 15th.

HSSP INTL (03626) stated that the company's public shareholding is not less than 25%, complying with the minimum public shareholding requirement.

Selected Announcement of A-shares | Nanjing Business & Tourism Corp.,Ltd.(600250.SH) Controlling Shareholder Nanjing Tourism Group Plans to Carry out Reform and Restructuring.

Shougang Langze (02553) has published a supplementary prospectus, expecting to be listed on July 15th.

HSSP INTL (03626) stated that the company's public shareholding is not less than 25%, complying with the minimum public shareholding requirement.

Selected Announcement of A-shares | Nanjing Business & Tourism Corp.,Ltd.(600250.SH) Controlling Shareholder Nanjing Tourism Group Plans to Carry out Reform and Restructuring.